Caio M. Rocha Lima

2.3k total citations
33 papers, 1.7k citations indexed

About

Caio M. Rocha Lima is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Caio M. Rocha Lima has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Epidemiology. Recurrent topics in Caio M. Rocha Lima's work include Neuroendocrine Tumor Research Advances (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Research Studies (9 papers). Caio M. Rocha Lima is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Research Studies (9 papers). Caio M. Rocha Lima collaborates with scholars based in United States, Canada and Peru. Caio M. Rocha Lima's co-authors include Mark R. Green, Laura A. Cisar, Wilson H. Miller, G. Gruia, A. Morganti, Nicoletta Orlando, Langdon L. Miller, Peter J. Hosein, Alejandro D. Ricart and Stewart Kroll and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and Annals of Oncology.

In The Last Decade

Caio M. Rocha Lima

32 papers receiving 1.7k citations

Peers

Caio M. Rocha Lima
Jonathan D. Mizrahi United States
Aristidis Polyzos Greece
E. Ramsay Camp United States
R. Schulick United States
Alison Backen United Kingdom
Joe Stephenson United States
Chunyi Hao China
Xin‐Da Zhou China
G. Deplanque France
Huaxiang Xu China
Jonathan D. Mizrahi United States
Caio M. Rocha Lima
Citations per year, relative to Caio M. Rocha Lima Caio M. Rocha Lima (= 1×) peers Jonathan D. Mizrahi

Countries citing papers authored by Caio M. Rocha Lima

Since Specialization
Citations

This map shows the geographic impact of Caio M. Rocha Lima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caio M. Rocha Lima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caio M. Rocha Lima more than expected).

Fields of papers citing papers by Caio M. Rocha Lima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caio M. Rocha Lima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caio M. Rocha Lima. The network helps show where Caio M. Rocha Lima may publish in the future.

Co-authorship network of co-authors of Caio M. Rocha Lima

This figure shows the co-authorship network connecting the top 25 collaborators of Caio M. Rocha Lima. A scholar is included among the top collaborators of Caio M. Rocha Lima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caio M. Rocha Lima. Caio M. Rocha Lima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chao, Lowell L. Hart, Taofeek K. Owonikoko, et al.. (2021). Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer. Cancer Chemotherapy and Pharmacology. 87(5). 689–700. 14 indexed citations
2.
Hosein, Peter J., Isildinha M. Reis, Vinicius Ernani, et al.. (2018). The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma. Journal of Gastrointestinal Oncology. 9(1). 135–139. 10 indexed citations
3.
Hart, Lowell L., Patrick J. Roberts, Renata Ferrarotto, et al.. (2017). P1.07-002 G1T28, a Cyclin Dependent Kinase 4/6 Inhibitor, in Combination with Topotecan for Previously Treated Small Cell Lung Cancer: Preliminary Results. Journal of Thoracic Oncology. 12(1). S696–S696. 1 indexed citations
4.
Hosein, Peter J., Ana Echenique, Arturo Loaiza‐Bonilla, et al.. (2014). Percutaneous Irreversible Electroporation for the Treatment of Colorectal Cancer Liver Metastases with a Proposal for a New Response Evaluation System. Journal of Vascular and Interventional Radiology. 25(8). 1233–1239.e2. 46 indexed citations
5.
Bayraktar, Ulas D., et al.. (2013). Comparison of Cancer Care and Outcomes between a Public Safety-Net Hospital and a Private Cancer Center. Journal of Health Care for the Poor and Underserved. 24(3). 1136–1149. 7 indexed citations
6.
Raez, Luis E., Kyriakos P. Papadopoulos, Alejandro D. Ricart, et al.. (2012). A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(2). 523–530. 411 indexed citations
7.
García-Buitrago, Mónica, et al.. (2012). Small-Cell Cancer of the Breast: What Is the Optimal Treatment? A Report and Review of Outcomes. Clinical Breast Cancer. 12(4). 287–292. 15 indexed citations
8.
Lima, Caio M. Rocha, Soley Bayraktar, Jessica MacIntyre, et al.. (2012). Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer. Cancer Investigation. 30(10). 727–731. 33 indexed citations
9.
Bayraktar, Soley & Caio M. Rocha Lima. (2012). Emerging cell-cycle inhibitors for pancreatic cancer therapy. Expert Opinion on Emerging Drugs. 17(4). 571–582. 11 indexed citations
10.
Hosein, Peter J., Gilberto Lopes, Jessica MacIntyre, et al.. (2012). A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 36(2). 151–156. 84 indexed citations
11.
Narayanan, Govindarajan, Peter J. Hosein, Geetika Arora, et al.. (2012). Percutaneous Irreversible Electroporation for Downstaging and Control of Unresectable Pancreatic Adenocarcinoma. Journal of Vascular and Interventional Radiology. 23(12). 1613–1621. 175 indexed citations
12.
García-Buitrago, Mónica, et al.. (2011). Sustained response to FOLFOX and Bevacizumab in metastatic bronchial carcinoid - A case report and review of the literature.. PubMed. 2(2). 117–21. 1 indexed citations
13.
Buzaid, Antônio C., et al.. (2011). MOC: Manual de oncologia clinica do Brasil. 780–780. 1 indexed citations
14.
Marsh, Robert, Caio M. Rocha Lima, David T. Levy, et al.. (2007). A Phase II Trial of Perifosine in Locally Advanced, Unresectable, or Metastatic Pancreatic Adenocarcinoma. American Journal of Clinical Oncology. 30(1). 26–31. 48 indexed citations
15.
Lima, Caio M. Rocha, Naiyer A. Rizvi, James E. Herndon, et al.. (2004). Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC. Annals of Oncology. 15(3). 410–418. 24 indexed citations
16.
Shoemaker, Laura, Umesh K. Arora, & Caio M. Rocha Lima. (2004). 5-Fluorouracil–Induced Coronary Vasospasm. Cancer Control. 11(2). 46–49. 63 indexed citations
17.
Lima, Caio M. Rocha & Alberto Chiappori. (2003). Treatment of relapsed small-cell lung cancer—a focus on the evolving role of topotecan. Lung Cancer. 40(3). 229–236. 18 indexed citations
18.
Lima, Caio M. Rocha, et al.. (2001). Beyond pancreatic cancer: Irinotecan and gemcitabine in solid tumors and hematologic malignancies. Seminars in Oncology. 28(3H). 34–43. 3 indexed citations
19.
Green, Mark R., Caio M. Rocha Lima, & Carol A. Sherman. (2000). Radiation and chemotherapy for patients with stage III non-small cell lung cancer. Seminars in Radiation Oncology. 10(4). 289–295. 9 indexed citations
20.
Leong, Swan Swan, Caio M. Rocha Lima, Carol A. Sherman, & Mark R. Green. (1999). The 1997 International Staging System for Non-Small Cell Lung Cancer. CHEST Journal. 115(1). 242–248. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan D. Mizrahi Breakdown of academic impact, for papers by Aristidis Polyzos Breakdown of academic impact, for papers by E. Ramsay Camp Breakdown of academic impact, for papers by R. Schulick Breakdown of academic impact, for papers by Alison Backen Breakdown of academic impact, for papers by Joe Stephenson Breakdown of academic impact, for papers by Chunyi Hao Breakdown of academic impact, for papers by Xin‐Da Zhou Breakdown of academic impact, for papers by G. Deplanque Breakdown of academic impact, for papers by Huaxiang Xu
Rankless by CCL
2026